SLC16A1 was undetectable in 2 normal pancreatic samples, but expressed in 11 out of 12 pancreatic cancer patients (6 with moderate-high expression, 1 with high expression) (Figures 12G-J). Here, SLC16A1 is linked to familial pancreatic carcinoma.